Skip to main content

Table 3 MIC and cumulative percent inhibited distributions for plazomicin, in relation to gentamicin and amikacin susceptibility (according EUCAST criteria)

From: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

Aminoglycoside susceptibility

No of isolates

No of isolates / (cumulative % of isolates) inhibited at plazomicin MIC (mg/L) of a

≤0.125

0.25

0.5

1

2

4

8

16

32

≥64d

Amikacin Sb

54

5

(9.3)

23

(51.9)

11

(72.2)

9

(88.9)

1

(90.7)

5

(100)

0

(−)

0

(−)

0

(−)

0

(−)

Amikacin NSc

246

3

(1.2)

55

(23.6)

56

(46.3)

74

(76.4)

24

(86.2)

8

(89.4)

3

(90.7)

0

(90.7)

0

(90.7)

23

(100)

Amikacin NS (excluding RMT positive isolates)

223

3

(1.3)

55

(26.0)

56

(51.1)

74

(84.3)

24

(95.1)

8

(98.7)

3

(100)

0

(−)

0

(−)

0

(−)

Gentamicin S

129

3

(2.3)

52

(42.6)

41

(74.4)

24

(93.0)

5

(96.9)

4

(100)

0

(−)

0

(−)

0

(−)

0

(−)

Gentamicin NS

171

5

(2.9)

26

(18.1)

26

(33.3)

59

(67.8)

20

(79.5)

9

(84.8)

3

(86.5)

0

(86.5)

0

(86.5)

23

(100)

Gentamicin NS (excluding RMT positive isolates)

148

5

(3.4)

26

(20.9)

26

(38.5)

59

(78.4)

20

(91.9)

9

(97.8)

3

(100)

0

(−)

0

(−)

0

(−)

Amikacin NS/Gentamicin NS

154

2

(1.3)

15

(11.0)

25

(27.3)

58

(64.9)

20

(77.9)

8

(83.1)

3

(85.1)

0

(85.1)

0

(85.1)

23

(100)

Amikacin NS/Gentamicin NS (excluding RMT positive isolates)

131

2

(1.5)

15

(13.0)

25

(32.1)

58

(76.3)

20

(91.6)

8

(97.7)

3

(100)

0

(−)

0

(−)

0

(−)

Amikacin NS/Gentamicin S

92

1

(1.1)

40

(44.6)

31

(78.3)

16

(95.7)

4

(100)

0

(−)

0

(−)

0

(−)

0

(−)

0

(−)

Amikacin S/Gentamicin NS

17

3

(17.6)

11

(82.4)

1

(88.2)

1

(94.1)

0

(94.1)

1

(100)

0

(−)

0

(−)

0

(−)

0

(−)

Amikacin S/Gentamicin S

28

1

(3.6)

8

(32.1)

6

(53.6)

8

(82.1)

1

(85.7)

4

(100)

0

(−)

0

(−)

0

(−)

0

(−)

All isolates excluding RMT positives

277

8

(2.9)

78

(31.0)

67

(55.2)

83

(85.2)

25

(94.2)

13

(98.9)

3

(100)

0

(−)

0

(−)

0

(−)

  1. a The MIC inhibiting 90% of isolates (MIC90) is bolded
  2. b S; susceptible
  3. c NS; non susceptible
  4. d All isolates (n = 23) with plazomicin MIC ≥64 mg/L harbored a 16S rRNA methylase gene